INFLUENZA, HUMAN
Clinical trials for INFLUENZA, HUMAN explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA, HUMAN trials appear
Sign up with your email to follow new studies for INFLUENZA, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA tech takes aim at the flu
⭐️ VACCINE ⭐️ CompletedThis study tested a new seasonal flu vaccine made with mRNA technology, similar to some COVID-19 vaccines. It involved 845 healthy adults to see how well their immune systems responded to different doses of the vaccine and to check for side effects. The goal was to gather data to…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 02:42 UTC
-
New flu shot for tots: can it beat more strains?
⭐️ VACCINE ⭐️ CompletedThis study tested a new flu vaccine designed to protect against four strains of the flu virus in very young children. It compared the new vaccine against existing three-strain vaccines to see if it triggered a better immune response and was equally safe. The trial involved over 1…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE3 • Sponsor: Butantan Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 02:41 UTC
-
Scientists test Next-Gen mRNA shot against future flu pandemics
⭐️ VACCINE ⭐️ CompletedThis was the first human study of a new type of mRNA flu vaccine designed to protect against potential future flu pandemics. Researchers tested three different doses in 212 healthy adults to see how safe it was and if it triggered a good immune response. They compared the new vac…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE1 • Sponsor: Arcturus Therapeutics, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test Next-Gen flu shot using mRNA tech
⭐️ VACCINE ⭐️ CompletedThis was the first human study of a new seasonal flu vaccine called ARCT-2138, which uses self-amplifying mRNA technology. It tested the vaccine's safety and ability to trigger an immune response in 139 healthy younger and older adults. The study compared different doses of the n…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE1 • Sponsor: Arcturus Therapeutics, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test mRNA tech against seasonal flu in landmark safety trial
⭐️ VACCINE ⭐️ CompletedThis was the first human study of a new mRNA-based flu vaccine candidate from GSK. It tested the safety and immune response of different doses in 324 healthy younger and older adults. The main goal was to see how well the body reacted to the vaccine and to identify any side effec…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:33 UTC
-
New mRNA tech takes aim at bird flu in major vaccine trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new mRNA-based vaccine designed to protect against a potential pandemic strain of bird flu (H5 influenza). Nearly 1,000 healthy adults aged 18 to 85 received different doses of the vaccine to find the safest and most effective amount. The main goals were to ch…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:39 UTC
-
Pfizer tests Next-Gen flu shot in landmark safety trial
⭐️ VACCINE ⭐️ CompletedThis study tested the safety of a new type of flu vaccine that uses self-amplifying RNA technology. Pfizer enrolled 440 healthy adults aged 18-49 to receive either the experimental vaccine, a standard flu shot, or a placebo. The main goal was to check for side effects and see how…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE1 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:38 UTC
-
Pfizer tests Next-Gen mRNA flu shot
⭐️ VACCINE ⭐️ CompletedThis study tested new mRNA-based flu vaccines to see if they are safe and how well they trigger an immune response. It involved 1,202 generally healthy adults who received either a new mRNA vaccine or a standard approved flu shot. Researchers monitored participants for about six …
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:38 UTC
-
One shot for two bugs? pfizer tests combo vaccine
⭐️ VACCINE ⭐️ CompletedThis study tested whether a single injection combining a licensed COVID-19 vaccine and a licensed flu vaccine is safe and works as well as getting two separate shots. It involved 644 healthy adults aged 50 and older. Researchers compared the combo shot to getting the vaccines sep…
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:38 UTC